Dec 19, 2011 - 12:42 pm
Posted by Market Wrap Daily | Posted in: Healthcare, Recent
Trius Therapeutics (NASDAQ: TSRX) shares slump in early trading Monday
Trius Therapeutics (NASDAQ: TSRX) shares are down by more than 13% after the biotech group released results from a Phase III clinical trial for its antibiotic drug candidate tedizolid.
Trius Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of antibiotics for life threatening infections.
Tags: biotech
Market Wrap Daily Categories
Recent
SIGN UP TODAY FOR FREE ALERTS
Tag Cloud